A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) C12N 15/88 (2006.01)
Patent
CA 2751268
The present invention is directed to the delivery of nucleic acids in a non- viral vector to cells by positively charged chitosan deriva-tives, including but not limited to chi-tosan-arginine, chitosan-lysine and chitosan-histidine.
La présente invention porte sur l'administration d'acides nucléiques dans un vecteur non viral à des cellules par dérivés de chitosane chargées positivement, comprenant mais sans s'y limiter, la chitosane-arginine, la chitosane-lysine et la chitosane-histidine.
Baker Shenda
Baxter Ruth
Rogelj Snezna
Wiesmann William P.
Gowling Lafleur Henderson Llp
Synedgen Inc.
LandOfFree
Nucleic acid delivery using modified chitosans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid delivery using modified chitosans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid delivery using modified chitosans will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1707488